Actionable news
0
All posts from Actionable news
Actionable news in DBVT: DBV TECHNOLOGIES S.A.,

XenoPort, Inc. And DBV Technologies SA: Two Healthcare Stocks With Opposing Momentum

XenoPort, Inc. (NASDAQ:XNPT) saw its stock price surge by more than 7% in pre-market trading today, owing to the success of its XP23829 treatment in s mid-stage psoriasis study. However, the momentum couldn’t last, as the stock has crumbled by more than 25% in early-afternoon trading. DBV Technologies SA – ADR (NASDAQ:DBVT) on the other hand also posted gains in pre-market trading today, of 3.09%, and continued that momentum into the regular trading session, with its stock price having risen by more than 7% by noon. The driving force behind this action was Morgan Stanley initiating coverage on the company with an ‘Overweight’ rating and a price target of $59, which provides an upside of 47.5% to the current trading levels.

Best Paying Medical Jobs with Least Education

An everyday investor does not have the time or the required skill-set to carry out an in-depth analysis of equities and identify companies with the best future prospects like a top healthcare fund with the knowledge and resources of Orbimed Advisors or Baker Bros. Advisors can. However, it is also not a good idea to pay the egregiously high fees that investment firms charge for their stock picking expertise. Thus a retail investor is better off to monkey the most popular stock picks among hedge funds by him or herself. But not just any picks mind you. Our research has shown that a portfolio based on hedge funds’ top stock picks (which are invariably comprised entirely of large-cap companies) falls considerably short of a...


More